Harnessing Ziziphora Flavonoids to Combat Ischemic Stroke via NRF2 and PI3K/Akt Pathways
science

Harnessing Ziziphora Flavonoids to Combat Ischemic Stroke via NRF2 and PI3K/Akt Pathways

NRF2 Editorial Team October 19, 2026
Quick Answer

New research reveals that flavonoids from the traditional medicinal herb Ziziphora clinopodioides protect the brain against ischemic stroke by activating the PI3K/Akt pathway and enhancing NRF2 antioxidant defenses. This dual action reduces oxidative stress, neuroinflammation, and preserves blood-brain barrier integrity, offering promising therapeutic potential for stroke patients. Discover how natural compounds like Diosmin, Glycitin, and Tilianin may revolutionize stroke recovery by boosting cellular defense mechanisms.

Introduction: Why This Matters

Ischemic stroke (IS) remains a leading cause of death and long-term disability worldwide. It results from interrupted blood flow to the brain, triggering oxidative stress, neuroinflammation, and damage to the blood-brain barrier (BBB). These pathological processes exacerbate neuronal injury and worsen outcomes.

Recent research highlights the critical role of cellular defense mechanisms, such as the NRF2 antioxidant pathway, in protecting brain tissue from ischemic damage. Finding natural compounds that can activate these protective pathways offers promising therapeutic potential.

Ziziphora clinopodioides, a traditional Uyghur medicinal herb, has been used for centuries to treat cardiovascular and cerebrovascular disorders. Its flavonoid-rich extracts (ZCF) are known for anti-inflammatory and antioxidant properties, but their neuroprotective mechanisms in ischemic stroke have been unclear—until now.

Study Overview: What Researchers Did

A team led by Zhuo Xingjie and colleagues investigated how ZCF exerts neuroprotection in ischemic stroke models. They combined advanced network pharmacology and transcriptomics to predict key signaling pathways targeted by ZCF.

Following these predictions, the researchers conducted both in vitro (cell culture) and in vivo (rat model) experiments. They assessed neurological deficits, brain infarct size, BBB integrity, and molecular markers related to inflammation, oxidative stress, and the PI3K/Akt signaling pathway.

To confirm the involvement of PI3K/Akt, they used a specific inhibitor (LY294002) to see if blocking this pathway reversed ZCF’s effects. Additionally, molecular docking and dynamics simulations identified which flavonoids in ZCF might directly interact with PI3K.

Key Findings: The Results

  • ZCF activates the PI3K/Akt pathway, a crucial intracellular signaling route that promotes cell survival and antioxidant responses.
  • ZCF treatment reduced cerebral infarct volume and preserved neuronal morphology in ischemic stroke rat models.
  • Blood-brain barrier integrity was protected by restoring tight junction proteins (ZO-1, Occludin, Claudin-5) and reducing harmful matrix metalloproteinases (MMP-9 and MMP-2).
  • ZCF rebalanced Angiopoietin-1/2 levels, decreased NaF permeability, and increased transendothelial electrical resistance (TEER), all markers of improved BBB function.
  • Blocking PI3K/Akt with LY294002 reversed ZCF’s protective effects, confirming this pathway’s central role.
  • ZCF inhibited the pro-inflammatory TLR4/NF-κB/NLRP3 axis, reducing cytokines IL-1β, IL-6, TNF-α, and oxidative stress marker MDA.
  • Importantly, ZCF upregulated NRF2 and antioxidant enzyme SOD, enhancing cellular defense against oxidative stress.
  • Molecular docking revealed flavonoids Diosmin, Glycitin, and Tilianin as active constituents binding stably to PI3K, restoring its activity and reducing inflammation in neuronal cells.

What This Means for You: Practical Takeaways

This study sheds light on how natural flavonoids from Ziziphora clinopodioides can protect the brain from ischemic injury by activating the PI3K/Akt pathway and boosting the NRF2 antioxidant response.

For patients and caregivers, these findings highlight the potential of plant-based compounds to complement existing stroke therapies by:

  • Reducing oxidative stress, a key driver of neuronal damage during stroke.
  • Suppressing neuroinflammation to limit secondary injury.
  • Preserving blood-brain barrier integrity, which is vital for maintaining brain homeostasis.
  • Enhancing cellular defense mechanisms through NRF2 activation, supporting long-term brain recovery.

While more clinical research is needed, the identification of specific flavonoids like Diosmin, Glycitin, and Tilianin opens avenues for developing targeted nutraceuticals or adjunct therapies for ischemic stroke.

Conclusion

The groundbreaking work by Zhuo Xingjie and colleagues demonstrates that flavonoids from Ziziphora clinopodioides exert significant neuroprotective effects against ischemic stroke. By modulating the PI3K/Akt signaling pathway and enhancing NRF2-mediated antioxidant defenses, ZCF reduces brain infarction, inflammation, and oxidative stress while preserving blood-brain barrier integrity.

This research not only validates traditional medicinal uses of Ziziphora but also provides a molecular basis for developing novel antioxidant therapies targeting cellular defense systems. Harnessing such natural compounds could revolutionize ischemic stroke treatment and improve patient outcomes.

References

For more detailed information, see the original study: Ziziphora clinopodioides Flavonoids exerts neuroprotective effects through PI3K/Akt pathway to improve ischemic stroke - Journal of Ethnopharmacology

Health & FDA Disclaimer

The statements on this website have not been evaluated by the Food and Drug Administration (FDA). The content provided is for informational and educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. This article does not constitute medical advice. Always consult your physician or a qualified healthcare provider before starting any new supplement, diet, or wellness program. Read our full medical disclaimer →